Moberg Pharma AB (publ) (STO:MOB)
Sweden
· Delayed Price · Currency is SEK 7.55
+0.20 (2.72%)
May 13, 2025, 5:29 PM CET
Moberg Pharma AB Revenue
Moberg Pharma AB had revenue of 3.87M SEK in the quarter ending March 31, 2025, with 371.83% growth. This brings the company's revenue in the last twelve months to 12.86M, up 1,468.29% year-over-year. In the year 2024, Moberg Pharma AB had annual revenue of 9.81M.
Revenue (ttm)
12.86M
Revenue Growth
+1,468.29%
P/S Ratio
26.69
Revenue / Employee
1.29M
Employees
10
Market Cap
343.20M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |
| Vimian Group AB | 4.24B |